Xiaoyong Luo
- Co-authors
- Zhengzhi ZouXinpeng ShiPeipei NieBaoyan WuWei XuBing LiHaocai ChangGuobin Huang
- Topics
- Gastric Cancer Management and Outcomes (3 papers)Lung Cancer Treatments and Mutations (3 papers)Epigenetics and DNA Methylation (2 papers)
- Partner nations
- China
In The Last Decade
Xiaoyong Luo
18 papers receiving 309 citations
Peers
Comparison fields: 5 of 61
- Molecular Biology 214
- Cancer Research 94
- Oncology 64
- Epidemiology 50
- Pulmonary and Respiratory Medicine 35
Countries citing papers authored by Xiaoyong Luo
This map shows the geographic impact of Xiaoyong Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyong Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyong Luo more than expected).
Fields of papers citing papers by Xiaoyong Luo
This network shows the impact of papers produced by Xiaoyong Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyong Luo. The network helps show where Xiaoyong Luo may publish in the future.
Co-authorship network of co-authors of Xiaoyong Luo
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyong Luo. A scholar is included among the top collaborators of Xiaoyong Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyong Luo. Xiaoyong Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 13 | |
| 3 | 6 | |
| 4 | 8 | |
| 5 | Apatinib suppresses breast cancer cells proliferation and invasion via angiomotin inhibition. | 7 |
| 6 | 20 | |
| 7 | 15 | |
| 8 | 70 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 8 | |
| 12 | 19 | |
| 13 | 35 | |
| 14 | Laparoscopic surgery is feasible for the treatment of rectal cancer after neoadjuvant chemoradiotherapy. | 2 |
| 15 | 8 | |
| 16 | 43 | |
| 17 | 6 | |
| 18 | 45 | |
| 19 | 0 |
About Xiaoyong Luo
Xiaoyong Luo is a scholar working on Cell Biology, Physiology and Oncology, having authored 19 papers that have together received 310 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (94 citations), Molecular Biology (214 citations) and Oncology (64 citations). Xiaoyong Luo has collaborated with scholars based in China. Frequent co-authors include Zhengzhi Zou, Xinpeng Shi, Peipei Nie, Baoyan Wu, Wei Xu, Bing Li, Haocai Chang, Guobin Huang, Bin Li and Benxin Hou. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.